InvestChile Portfolio Closes the First Half of the Year With 12.6% More Projects and Over 18,000 New Jobs
Santiago, Chile, Aug 22, 2023 – (ACN Newswire) – InvestChile, the Foreign Investment Promotion Agency,…
Month: August 2023
AeroVironment, Inc. to Acquire Tomahawk Robotics
AeroVironment’s unmanned systems paired with Tomahawk Robotics’ AI-enabled technology will allow warfighters to operate various…
Snappy Kraken Unleashes AI to Turbocharge Advisors’ Email Marketing Efforts
Innovative AI-powered email builder serves as all-in-one, time-saving solution for crafting captivating emails ORMOND BEACH,…
Pyramid Analytics and Smollan forge international partnership
Global retail specialist Smollan and next-gen analytics software provider Pyramid Analytics collaborate to empower businesses…
Sonny Patel Joins Socotra as Chief Product and Technology Officer, Bringing Decades of Fortune 500 Experience
AUSTIN, Texas–(BUSINESS WIRE)–Socotra, the leading provider of modern, cloud-based technology for insurers worldwide, announced today…
Myriad Genetics and Onsite Women’s Health Partner to Help More Women Understand Breast Cancer Risk
New collaboration increases access to genetic testing and can help identify patients with a high-risk…
Myriad Genetics and Onsite Women’s Health Partner to Help More Women Understand Breast Cancer Risk
New collaboration increases access to genetic testing and can help identify patients with a high-risk…
Independent Panel of Renowned Pediatric Endocrinologists to Discuss Pediatric Growth Hormone Deficiency and the Therapeutic Landscape
Virtual Webinar to be held September 5, 2023, at 11:00 AM Eastern Time AUSTIN, Texas,…
Independent Panel of Renowned Pediatric Endocrinologists to Discuss Pediatric Growth Hormone Deficiency and the Therapeutic Landscape
Virtual Webinar to be held September 5, 2023, at 11:00 AM Eastern Time AUSTIN, Texas,…
Ashvattha Therapeutics Presents Promising Preclinical Data on New Dendranib Nanomedicine Candidate ASH41020 at the 16th International Society of Neuroimmunology Congress (ISNI)
Data demonstrated that ASH41020, a novel CSFR1 tyrosine kinase inhibitor ‘dendranib’, directs macrophage polarization toward…
Ashvattha Therapeutics Presents Promising Preclinical Data on New Dendranib Nanomedicine Candidate ASH41020 at the 16th International Society of Neuroimmunology Congress (ISNI)
Data demonstrated that ASH41020, a novel CSFR1 tyrosine kinase inhibitor ‘dendranib’, directs macrophage polarization toward…
Shockwave Medical to Participate in Upcoming Investor Conferences
SANTA CLARA, Calif., Aug. 22, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a…
SELLAS Life Sciences Independent Data Monitoring Committee Recommends Galinpepimut-S REGAL Trial to Continue Without any Modifications
REGAL Interim Analysis Expected by Late 2023/Early 2024 Enrollment Expected to be Completed in Q4…
Shockwave Medical to Participate in Upcoming Investor Conferences
SANTA CLARA, Calif., Aug. 22, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a…
SELLAS Life Sciences Independent Data Monitoring Committee Recommends Galinpepimut-S REGAL Trial to Continue Without any Modifications
REGAL Interim Analysis Expected by Late 2023/Early 2024 Enrollment Expected to be Completed in Q4…
Reflect Scientific Secures $200,000 Order from Prominent Bio-Pharma Client for Blast Freezers
OREM, Utah, Aug. 22, 2023 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (Symbol: RSCF), a leading…
Longeveron Rights Offering Subscription Period Begins
MIAMI, Aug. 22, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN NASDAQ: LGVNR) (“Longeveron” or…
Reflect Scientific Secures $200,000 Order from Prominent Bio-Pharma Client for Blast Freezers
OREM, Utah, Aug. 22, 2023 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (Symbol: RSCF), a leading…
Longeveron Rights Offering Subscription Period Begins
MIAMI, Aug. 22, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN NASDAQ: LGVNR) (“Longeveron” or…
PROCEPT BioRobotics® Announces First Commercial Aquablation Therapy Procedures in Japan
REDWOOD CITY, Calif., Aug. 22, 2023 (GLOBE NEWSWIRE) — PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT…